Objectives: The purpose of the study was to compare the efficacy of a product containing cranberry and propolis (DUAB) to placebo for reducing frequency of cystitis in women with recurrent acute cystitis. Method: A multicenter, placebo-controlled, randomized study of women aged >18 years with at least 4 episodes of cystitis in the previous 12 months was performed. The number of cystitis episodes over a 6-month follow-up was the primary end point. Results: Forty-two women were included in the cranberry + propolis group, and 43 women were in the placebo group. The mean age was 53 ± 18 years, with 6.2 ± 3.6 cystitis episodes in the previous year, with no differences between the 2 groups. The mean number of infections was lower in the propolis + cranberry group (respectively, 2.3 ± 1.8 vs. 3.1 ± 1.8). The total number of cystitis episodes in the first 3 months was lower in the propolis + cranberry group (0.7 ± 1.1 vs. 1.3 ± 1.1, p = 0.0257) after adjusting for water consumption. The mean time to onset of the first urinary tract infection (UTI) was also significantly longer in the propolis + cranberry group (69.9 ± 45.8 days vs. 43.3 ± 45.9, p = 0.0258). Tolerance to the treatments was good and comparable in both groups. Conclusions: We demonstrate for the first time that cranberry and propolis supplementation significantly reduces the incidence of UTIs during the first 3 months and delays the onset of an episode of cystitis.

Keywords:
Urinary infection, Recurrence, Cranberry
1.
Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs.
Ann Epidemiol
. 2000 Nov;10(8):509–15.
2.
Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.
Microbes Infect
. 2003 Apr;5(5):449–56.
3.
Elkharrat D, Arrouy L, Benhamou F, Dray A, Grenet J, Corre AL. Épidémiologie de l’infection urinaire communautaire de l’adulte en France. Les infections urinaires. Paris: Springer, 2007, pp 1–20. (Monographies en Urologie). http://link.springer.com/chapter/10.1007/978-2-287-48617-3_1 (accessed December 7, 2016).
4.
Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens.
Dis Mon
. 2003 Feb;49(2):71–82.
5.
Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women.
Am J Epidemiol
. 2000 Jun;151(12):1194–205.
6.
Müller CM, Aberg A, Straseviçiene J, Emody L, Uhlin BE, Balsalobre C. Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP.
PLoS Pathog
. 2009 Feb;5(2):e1000303.
7.
Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, et al. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131.
PLoS One
. 2012;7(3):e34294.
8.
Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.
Curr Opin Microbiol
. 2010 Oct;13(5):558–64.
9.
Arpin C, Coulange L, Dubois V, André C, Fischer I, Fourmaux S, et al. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.
Antimicrob Agents Chemother
. 2007 Sep;51(9):3440–4.
10.
Lavigne JP, Bourg G, Botto H, Sotto A. [Cranberry (Vaccinium macrocarpon) and urinary tract infections: study model and review of literature].
Pathol Biol (Paris)
. 2007 Nov;55(8-9):460–4.
11.
Lavigne JP, Vitrac X, Bernard L, Bruyère F, Sotto A. Propolis can potentialise the anti-adhesion activity of proanthocyanidins on uropathogenic Escherichia coli in the prevention of recurrent urinary tract infections.
BMC Res Notes
. 2011 Nov;4(1):522.
12.
Jepson RG, Craig JC. Cranberries for preventing urinary tract infections.
Cochrane Database Syst Rev
. 2008 Jan;(1):CD001321.
13.
Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarova-Yarovaya Y, Chen S, et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial.
Mayo Clin Proc
. 2012 Feb;87(2):143–50.
14.
Maki KC, Kaspar KL, Khoo C, Derrig LH, Schild AL, Gupta K. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection.
Am J Clin Nutr
. 2016 Jun;103(6):1434–42.
15.
Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials.
Arch Intern Med
. 2012 Jul;172(13):988–96.
16.
Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012 Oct;10:CD001321.
17.
Harmidy K, Tufenkji N, Gruenheid S. Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One. 2011;6:e27267.
18.
Feliciano RP, Meudt JJ, Shanmuganayagam D, Krueger CG, Reed JD. Ratio of “A-type” to “B-type” proanthocyanidin interflavan bonds affects extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells.
J Agric Food Chem
. 2014 May;62(18):3919–25.
19.
Krueger CG, Reed JD, Feliciano RP, Howell AB. Quantifying and characterizing proanthocyanidins in cranberries in relation to urinary tract health.
Anal Bioanal Chem
. 2013 May;405(13):4385–95.
20.
Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules.
Clin Microbiol Infect
. 2008 Apr;14(4):350–5.
21.
Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial.
Clin Infect Dis
. 2011 Jan;52(1):23–30.
22.
Afshar K, Stothers L, Scott H, MacNeily AE. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial.
J Urol
. 2012 Oct;188(4 Suppl):1584–7.
23.
Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections.
Cochrane Database Syst Rev
. 2001;(3):CD001321.
24.
Jepson RG, Mihaljevic L, Craig J. Cranberries for Preventing Urinary Tract Infections.
Cochrane Database Syst Rev
. 2004;CD001321.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.